Appili Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Appili Therapeutics generated cash of -$2,464,425, which is more than the previous year. Cash used in financing activities reached the amount of $122,045 last year. Net change in cash is therefore -$2,371,389.
Cash Flow
| 2018 | -3.30M | -63.22K | 7.63M |
|---|---|---|---|
| 2020 | -4.26M | -1.13K | 9.36M |
| 2021 | -11.45M | -4.99M | 17.01M |
| 2023 | -10.09M | -3.17K | 5.90M |
| 2024 | -2.46M | -29.06K | 122.04K |
APLI.TO Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|
Cash at beginning of period | 2.46M | 6.66M | 10.50M | 5.42M | 1.34M |
Operating activities | |||||
Net income | -3.78M | -9.24M | -14.32M | -5.41M | -3.97M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 13.66K | 6.26K | 14.83K | 17.75K | 17.66K |
Stock-based compensation expense | 191.34K | 875.12K | 1.17M | 456.70K | 402.61K |
| Deferred income tax benefit | 191.34K | 875.12K | 1.17M | 456.70K | 402.61K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -752.55K | 346.69K | -859.81K | 153.02K | -662.10K |
Inventories | 0 | 4.15M | 39.19K | 65.25K | -104.44K |
Accounts payable | 1.37M | -4.15M | 3.20M | 19.25K | 455.92K |
Cash generated by operating activities | -2.46M | -10.09M | -11.45M | -4.26M | -3.30M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | -20.01M | -54 | -10.17K |
Investments In Property Plant And Equipment | -29.71K | -3.17K | -8.44K | -1.08K | -53.05K |
Acquisitions Net | 0 | 0 | 4.98M | 0 | 0 |
Cash generated by investing activities | -29.06K | -3.17K | -4.99M | -1.13K | -63.22K |
Financing activities | |||||
Common Stock Issued | 0 | 3.21M | 13.06M | 7.94M | 7.42M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 203.57K | 2.41M | -17.61K | 189.21K | 570.1K |
Cash used in financing activities | 122.04K | 5.90M | 17.01M | 9.36M | 7.63M |
Net Change In Cash | -2.37M | -4.19M | 553.30K | 5.08M | 4.38M |
Cash at end of period | 94.49K | 2.46M | 11.06M | 10.50M | 5.72M |
| Data source | Data source | Data source | Data source | Data source |